Literature DB >> 21614537

Genetic counseling for frontotemporal dementias.

Kimberly A Quaid1.   

Abstract

Frontotemporal dementia (FTD) is an umbrella term for a heterogeneous group of neurodegenerative disorders that are characterized by changes in cognition, language, personality, and social functioning. Approximately 40% of individuals with FTD have a family history of dementia, but less than 10% have a clear autosomal dominant pattern of inheritance. However, establishing a clear mode of inheritance in FTD is complicated by clinical heterogeneity, variable expression, phenocopies, misdiagnosis, early death due to other causes, missing medical records, and lost family histories. Mutations in the microtubule-associated protein tau and progranulin genes have been reported in the majority of hereditary cases, making genetic testing of at-risk individuals possible. The first step in counseling a family with a history of FTD is to take a comprehensive family history with confirmation of any diagnosis in a family member with medical records to the extent possible. If the pedigree analysis suggests an autosomal dominant pattern of inheritance, genetic testing of an affected relative may be offered to the family to determine if a mutation is present. If a mutation is found, relatives interested in pursuing genetic testing should be referred to a genetic counselor familiar with genetic testing for neurodegenerative disorders. Predictive testing of unaffected and at-risk relatives should only be offered in the context of a comprehensive genetic counseling protocol offering pre- and post-test counseling and support. One survey of at-risk individuals in a large family with FTD found that 50% were interested in testing. In one study actually offering genetic testing for FTD, the rate of uptake of testing was only 8.4%. A more recent study estimated the uptake for testing for FTD to be somewhere between 7% and 17% and attributed the low uptake to family resistance to testing. While genetic testing may be appropriate for some families with Alzheimer's disease and FTD, uptake of testing may be expected to be low.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21614537     DOI: 10.1007/s12031-011-9557-8

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  19 in total

Review 1.  Adolescent separation-individuation and family transitions.

Authors:  J A Daniels
Journal:  Adolescence       Date:  1990

2.  Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia.

Authors:  Gaia Skibinski; Nicholas J Parkinson; Jeremy M Brown; Lisa Chakrabarti; Sarah L Lloyd; Holger Hummerich; Jørgen E Nielsen; John R Hodges; Maria Grazia Spillantini; Tove Thusgaard; Sebastian Brandner; Arne Brun; Martin N Rossor; Anders Gade; Peter Johannsen; Sven Asger Sørensen; Susanne Gydesen; Elizabeth M C Fisher; John Collinge
Journal:  Nat Genet       Date:  2005-07-24       Impact factor: 38.330

3.  Emotional reactions to predictive testing in Alzheimer's disease and other inherited dementias.

Authors:  José L Molinuevo; Luis Pintor; Josep M Peri; Alberto Lleó; Rafael Oliva; Teodor Marcos; Rafael Blesa
Journal:  Am J Alzheimers Dis Other Demen       Date:  2005 Jul-Aug       Impact factor: 2.035

4.  Interest in genetic testing in pallido-ponto-nigral degeneration (PPND): a family with frontotemporal dementia with Parkinsonism linked to chromosome 17.

Authors:  C A McRae; G Diem; T G Yamazaki; A Mitek; Z K Wszolek
Journal:  Eur J Neurol       Date:  2001-03       Impact factor: 6.089

5.  New genes, new dilemmas: FTLD genetics and its implications for families.

Authors:  Jill S Goldman; Jennifer Adamson; Anna Karydas; Bruce L Miller; Mike Hutton
Journal:  Am J Alzheimers Dis Other Demen       Date:  2007 Dec-2008 Jan       Impact factor: 2.035

Review 6.  Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia.

Authors:  John C van Swieten; Peter Heutink
Journal:  Lancet Neurol       Date:  2008-09-02       Impact factor: 44.182

7.  Predictive testing for Huntington disease: I. Description of a pilot project in British Columbia.

Authors:  S Fox; M Bloch; M Fahy; M R Hayden
Journal:  Am J Med Genet       Date:  1989-02

8.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

Authors:  M G Spillantini; J R Murrell; M Goedert; M R Farlow; A Klug; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

9.  Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.

Authors:  Giles D J Watts; Jill Wymer; Margaret J Kovach; Sarju G Mehta; Steven Mumm; Daniel Darvish; Alan Pestronk; Michael P Whyte; Virginia E Kimonis
Journal:  Nat Genet       Date:  2004-03-21       Impact factor: 38.330

10.  A decade of genetic counseling in frontotemporal dementia affected families: few counseling requests and much familial opposition to testing.

Authors:  S R Riedijk; M F N Niermeijer; D Dooijes; A Tibben
Journal:  J Genet Couns       Date:  2009-04-10       Impact factor: 2.537

View more
  5 in total

1.  The genetics and neuropathology of neurodegenerative disorders: perspectives and implications for research and clinical practice.

Authors:  Vivianna M Van Deerlin
Journal:  Acta Neuropathol       Date:  2012-09       Impact factor: 17.088

2.  A study of the practice of individual genetic counsellors and genetic nurses in Europe.

Authors:  Heather Skirton; Christophe Cordier; Debby Lambert; Ulrika Hosterey Ugander; Marie-Antoinette Voelckel; Anita O'Connor
Journal:  J Community Genet       Date:  2012-09-28

Review 3.  Ethical issues in neurogenetics.

Authors:  Wendy R Uhlmann; J Scott Roberts
Journal:  Handb Clin Neurol       Date:  2018

Review 4.  A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.

Authors:  Jane S Paulsen; Martha Nance; Ji-In Kim; Noelle E Carlozzi; Peter K Panegyres; Cheryl Erwin; Anita Goh; Elizabeth McCusker; Janet K Williams
Journal:  Prog Neurobiol       Date:  2013-09-11       Impact factor: 11.685

5.  The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical Implications.

Authors:  Helena Gossye; Christine Van Broeckhoven; Sebastiaan Engelborghs
Journal:  Front Neurosci       Date:  2019-08-06       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.